ETF · NYSE Arca: PBE
PBE — Invesco Biotechnology & Genome ETF
Invesco Biotechnology & Genome ETF (PBE) is an exchange-traded fund listed on NYSE Arca. On Bright Analyst you can analyze PBE's holdings, sector allocation, performance, expense ratio, dividends and similar ETFs, alongside an AI-written fund analysis.
Key facts
- Ticker symbol
- PBE
- Exchange
- NYSE Arca
- ISIN
- US46137V7872
- Security type
- Exchange-traded fund
Research PBE
- Price Chart — Interactive price history with AI commentary.
- Fund Analysis — Fund profile, strategy, index and an AI-written analysis.
- Performance — Returns, valuation and expense ratio against its category.
- Holdings — Every position with its weight, sector and asset type.
- Allocation — Sector, asset-class and top-holding concentration.
- Peers — Comparison with similar ETFs on cost, returns and holdings.
- Dividends — Dividend yield and distribution history.
- News — Latest headlines about the fund and its issuer.
Frequently asked questions
What is the PBE ETF?
PBE is the ticker symbol of Invesco Biotechnology & Genome ETF, an exchange-traded fund listed on NYSE Arca with ISIN US46137V7872.
What does PBE hold?
The PBE Holdings page lists every position in Invesco Biotechnology & Genome ETF with its portfolio weight, and the Allocation page breaks the fund down by sector and asset class.
Does PBE pay a dividend?
The PBE Dividends page shows the fund's dividend yield and distribution history for any period in which it has paid distributions.
What are alternatives to PBE?
The PBE Peers page compares Invesco Biotechnology & Genome ETF with similar ETFs on cost, performance and holdings.
For information only — not investment advice.